Article
Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles
1 Apr 2015
Abstract excerpt
Influenza A virus poses a major threat to human health, causing outbreaks from time to time. Currently available vaccines employ inactivated viruses of different strains to provide protection against influenza virus infection. However, high mutation rates of influenza virus hemagglutinin (H) and neuraminidase (N) glycoproteins give rise to vaccine escape mutants. Thus, an effective vaccine providing protection...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
